Urinary Tract Infections

Infectious Disease·MeSH: Urinary Tract Infections

13 drugs in development·11 companies·3 clinical trials

Drug Pipeline by Phase

Approved(10)

Drug	Company
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	SUNSET ISLAND GROUP (SUN)
Cefaclor Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
orlynvah	Iterum Therapeutics plc (ITRM)
zemdri	Achaogen, Inc. (AKAO)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(1)

Drug	Company
tebipenem hbr	Spero Therapeutics, Inc. (SPRO)

Phase 1(1)

Drug	Company
etx0282cpdp	Entasis Therapeutics Holdings Inc. (ETTX)

BLA Filed(1)

Drug	Company
plazomicin	Achaogen, Inc. (AKAO)

BioSniper tracks 13 drugs in development for Urinary Tract Infections across 11 companies.

There are 3 clinical trials targeting Urinary Tract Infections tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.